128 related articles for article (PubMed ID: 20960191)
1. Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy.
Shitara K; Matsuo K; Oze I; Mizota A; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
Cancer Chemother Pharmacol; 2011 Aug; 68(2):301-7. PubMed ID: 20960191
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies.
Tan X; Wen Q; Wang R; Chen Z
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1077-1085. PubMed ID: 28910204
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer.
Bogani G; Sabatucci I; Maltese G; Lecce F; Signorelli M; Martinelli F; Chiappa V; Indini A; Leone Roberti Maggiore U; Borghi C; Fucà G; Ditto A; Raspagliesi F; Lorusso D
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():41-45. PubMed ID: 27888705
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Neonatal Neutropenia and Leukopenia After In Utero Exposure to Chemotherapy for Maternal Cancer.
La Nasa M; Gaughan J; Cardonick E
Am J Clin Oncol; 2019 Apr; 42(4):351-354. PubMed ID: 30789413
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer.
Sugiura T; Ariyoshi Y; Negoro S; Nakamura S; Ikegami H; Takada M; Yana T; Fukuoka M
Invest New Drugs; 2005 Aug; 23(4):331-7. PubMed ID: 16012792
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer.
Han Y; Yu Z; Wen S; Zhang B; Cao X; Wang X
Breast Cancer Res Treat; 2012 Jan; 131(2):483-90. PubMed ID: 21971729
[TBL] [Abstract][Full Text] [Related]
7. Bojungikgi-tang for Chemotherapy-induced Leukopenia: A Systematic Review and Meta-Analysis.
Ahn L; Park SW; Choi DJ
Integr Cancer Ther; 2024; 23():15347354231226115. PubMed ID: 38427798
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
Di Maio M; Gridelli C; Gallo C; Shepherd F; Piantedosi FV; Cigolari S; Manzione L; Illiano A; Barbera S; Robbiati SF; Frontini L; Piazza E; Ianniello GP; Veltri E; Castiglione F; Rosetti F; Gebbia V; Seymour L; Chiodini P; Perrone F
Lancet Oncol; 2005 Sep; 6(9):669-77. PubMed ID: 16129367
[TBL] [Abstract][Full Text] [Related]
9. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
Bin Q; Li J; Liao C; Cao Y; Gao F
Colorectal Dis; 2011 Aug; 13(8):837-45. PubMed ID: 20050863
[TBL] [Abstract][Full Text] [Related]
10. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
Bohlius J; Reiser M; Schwarzer G; Engert A
Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
[TBL] [Abstract][Full Text] [Related]
11. The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: A systematic review with meta-analysis.
Alenzi EO; Kelley GA
J Diabetes Complications; 2017 Jan; 31(1):267-272. PubMed ID: 27751709
[TBL] [Abstract][Full Text] [Related]
12. Hematologic toxicity assessment in solid tumor patients treated with cetuximab: a pooled analysis of 18 randomized controlled trials.
Cui R; Chu L; Liu ZQ; Xiao YY; Zhu XL; Chen YJ; Xu Q
Int J Cancer; 2015 Feb; 136(4):936-44. PubMed ID: 24975040
[TBL] [Abstract][Full Text] [Related]
13. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
Rusthoven J; Bramwell V; Stephenson B
Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
[TBL] [Abstract][Full Text] [Related]
14. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer.
Miyata H; Yano M; Yasuda T; Hamano R; Yamasaki M; Hou E; Motoori M; Shiraishi O; Tanaka K; Mori M; Doki Y
Clin Nutr; 2012 Jun; 31(3):330-6. PubMed ID: 22169459
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents.
Rahman A; Mican LM; Fischer C; Campbell AH
Ann Pharmacother; 2009 May; 43(5):822-30. PubMed ID: 19401471
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of chemotherapy-induced neutropenia with the biosimilar filgrastim: a non-interventional observational study of clinical practice patterns.
Tesch H; Ulshöfer T; Vehling-Kaiser U; Ottillinger B; Bulenda D; Turner M
Oncol Res Treat; 2015; 38(4):146-52. PubMed ID: 25877937
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association study of epirubicin-induced leukopenia in Japanese patients.
Srinivasan Y; Sasa M; Honda J; Takahashi A; Uno S; Kamatani N; Kubo M; Nakamura Y; Zembutsu H
Pharmacogenet Genomics; 2011 Sep; 21(9):552-8. PubMed ID: 21799462
[TBL] [Abstract][Full Text] [Related]
18. Growth factor use in medication-induced hematologic toxicity.
Miller RC; Steinbach A
J Pharm Pract; 2014 Oct; 27(5):453-60. PubMed ID: 25249588
[TBL] [Abstract][Full Text] [Related]
19. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
Maione P; Rossi A; Di Maio M; Gridelli C
Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
[TBL] [Abstract][Full Text] [Related]
20. Conflicting Data on the Incidence of Leukopenia and Neutropenia After Heated Intraperitoneal Chemotherapy with Mitomycin C.
Feferman Y; Bhagwandin S; Kim J; Aycart SN; Feingold D; Labow DM; Sarpel U
Ann Surg Oncol; 2017 Dec; 24(13):3831-3836. PubMed ID: 29027153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
